Persistent Systems Launches PaxPharma, Compliance-Based Design to Print Automation for the Pharmaceutical Industry

Persistent Systems Launches PaxPharma, Compliance-Based Design to Print Automation for the Pharmaceutical Industry

PHILADELPHIA, PA — (Marketwire) — 02/26/13 — (BOMBAY: PERSISTENT) (NSE: PERSISTENT), the global leader in software product and technology services, today announced the immediate availability of PaxPharma, a compliance-based, Design to Print (D2P) automation solution designed specifically for pharmaceutical packaging and product lifecycle management (PLM). The company unveiled the solution at this year-s conference being held February 26 and 27 at the Hilton Philadelphia City Avenue Hotel.

Strategic Manufacturing Award: Werum’s PAS-X is part of prize-winning IT program of Rottapharm | Madaus

Strategic Manufacturing Award: Werum’s PAS-X is part of prize-winning IT program of Rottapharm | Madaus

The pharmaceutical company Rottapharm | Madaus has won the 2012 Strategic Manufacturing Award in the category “Outstanding Achievement in Continuous Improvement” and the cross-competition “SMA e-F@ctory Hall of Fame” award for its Irish production plant in Dublin. The prizes pay tribute to the Continuous Improvement Program of Rottapharm | Madaus, in which the PAS-X Manufacturing IT Business Platform of Werum plays an important role.

Generic Injectables Market Exceeds $11 Billion

Generic Injectables Market Exceeds $11 Billion

ROCKVILLE, MD — (Marketwire) — 08/08/11 — MarketResearch.com has announced the addition of the new report "" to their collection of market reports. For more information, visit .The injectables sector exceeds US$11.2 billion and numerous high-value products will face patent expiry in major markets over the next decade. This critical new report evaluates the markets, players and products in detail.As companies seek new ways to gain a competitive edge in maturing generics markets,